Ofloxacin Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition
Ofloxacin Price Trend, Index and Forecast
Track the latest insights on ofloxacin price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.
Ofloxacin Prices Outlook Q2 2026
- USA: USD 50,840/MT
- China: USD 41,800/MT
- Germany: USD 47,069/MT
- France: USD 48,010/MT
- Canada: USD 43,890/MT
Ofloxacin Price Chart
Get real-time access to monthly/quaterly/yearly prices, Request Sample
During the second quarter of 2026, the ofloxacin prices in the USA reached 50,840 USD/MT in June. The market moved upward as supply availability remained relatively constrained across the generic pharmaceutical sector. Manufacturing disruptions and quality related limitations affecting sterile formulations contributed to tighter availability and encouraged buyers to secure material more proactively. Higher upstream costs for aromatic feedstocks and other chemical inputs also increased API manufacturing expenses.
During the second quarter of 2026, the ofloxacin prices in China reached 41,800 USD/MT in June. Prices increased as upstream chemical costs remained firm and continued to influence API manufacturing economics. Aromatic feedstock availability also affected producer costs, while tighter availability of selected chemical inputs encouraged manufacturers to maintain higher offers. Domestic pharmaceutical production provided a stable consumption base, while export requirements supported additional demand from overseas formulation markets.
During the second quarter of 2026, the ofloxacin prices in Germany reached 47,069 USD/MT in June. The market recorded an upward movement as pharmaceutical manufacturers faced continued cost pressure across chemical and energy intensive production activities. Demand from pharmaceutical formulation remained relatively stable, providing a firm consumption base for the API. Higher costs for upstream chemical materials also influenced production economics and encouraged suppliers to maintain firmer quotations.
During the second quarter of 2026, the ofloxacin prices in France reached 48,010 USD/MT in June. The market experienced upward price pressure as pharmaceutical manufacturers continued to manage elevated production and procurement costs. Demand from the healthcare sector remained supportive because ofloxacin continues to serve as an established antibacterial active ingredient in selected formulations. Higher upstream chemical expenses contributed to increased manufacturing costs, while international sourcing conditions influenced the availability and landed cost of pharmaceutical ingredients.
During the second quarter of 2026, the ofloxacin prices in Canada reached 43,890 USD/MT in June. Canadian prices increased as pharmaceutical buyers faced firmer international procurement costs and continued attention to API availability. The market remained influenced by overseas supply because pharmaceutical ingredients are traded through interconnected global manufacturing and distribution networks. Higher costs for chemical feedstocks increased the production economics of ofloxacin, while logistics and import related expenses added to delivered costs for downstream buyers.
.webp)
Regional Coverage
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing ofloxacin prices.
Europe Ofloxacin Price Trend
Q2 2026:
The ofloxacin price index in Europe moved upward as pharmaceutical demand remained stable while production costs continued to influence supplier quotations. Germany and France both recorded higher prices, reflecting the combined effect of firm pharmaceutical consumption and elevated upstream manufacturing expenses. Energy and chemical input costs remained relevant because API production depends on several chemical processing stages and supporting utilities. European manufacturers and distributors also continued to monitor international pharmaceutical supply conditions, as dependence on globally integrated API networks can increase exposure to logistics disruptions and supplier availability. Procurement strategies remained focused on supply reliability, particularly for pharmaceutical manufacturers requiring consistent API availability.
This analysis can be extended to include detailed ofloxacin price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Ofloxacin Price Trend
Q2 2026:
The ofloxacin price index in North America increased as supply constraints and higher manufacturing costs influenced the market. The United States recorded a stronger upward movement, while Canada also experienced firmer pricing. Availability of generic pharmaceutical ingredients remained an important consideration because manufacturing disruptions and quality related issues can reduce supply to formulation producers. The market was further influenced by higher costs for chemical feedstocks and energy intensive processing. Healthcare demand continued to provide a stable foundation for ofloxacin consumption, particularly across established pharmaceutical applications. Buyers remained focused on securing dependable API supplies, which supported procurement activity despite higher prices. International sourcing and logistics also affected regional costs because pharmaceutical supply chains remain dependent on cross border movement of active ingredients and intermediates.
Specific ofloxacin historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Ofloxacin Price Trend
Q2 2026:
The study includes ofloxacin price trends across the Middle East and Africa, taking into consideration variables that have a direct impact on market prices, such as regional industrial expansion, natural resource availability, and geopolitical conflicts.
In addition to region-wise data, information on ofloxacin prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Ofloxacin Price Trend
Q2 2026:
The Asia Pacific ofloxacin market moved upward as manufacturing costs and pharmaceutical demand provided support. China remained an important production and supply center, benefiting from its established chemical and pharmaceutical manufacturing infrastructure. Higher costs for aromatic feedstocks and other upstream materials influenced the economics of API production and encouraged firmer supplier quotations. Domestic pharmaceutical manufacturing provided consistent consumption, while export demand added support from international buyers. Supply chain conditions remained significant because regional producers serve pharmaceutical markets across multiple countries. Buyers continued to monitor raw material availability and production schedules to manage procurement risks. India also remained important within the broader regional pharmaceutical supply network, although its dependence on Chinese starting materials for several APIs and pharmaceutical intermediates creates exposure to international supply conditions.
This ofloxacin price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Ofloxacin Price Trend
Q2 2026:
The analysis of ofloxacin prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Ofloxacin Pricing Report, Market Analysis, and News
IMARC's latest publication, “Ofloxacin Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition,” presents a detailed examination of the ofloxacin market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of ofloxacin at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed ofloxacin prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting ofloxacin pricing, such as the dynamics of supply and demand, geopolitical influences, and sector specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.
Ofloxacin Industry Analysis
The global ofloxacin market size reached USD 1.20 Billion in 2025. By 2034, IMARC Group expects the market to reach USD 1.69 Billion, at a projected CAGR of 3.89% during 2026-2034. Ofloxacin market growth is supported by continued pharmaceutical demand for antibacterial formulations, established generic medicine production, and sustained global healthcare requirements for treating bacterial infections, which encourage manufacturers to maintain reliable API supplies.
Latest News and Developments:
- March 2021: Vivimed Labs Ltd., a major player of global specialty chemicals and medicines that came from India, got permission issued for a combination consisting of Ornidazole and Ofloxacin tablets. Besides, this mix is prepared for treating a broad range of bacteria and protozoan infections which allow a wider use of ofloxacin in medicine. The approval reflects a major progression as it eminently combines the broad-spectrum antibacterial nature of Ofloxacin with the antiprotozoal nature of Ornidazole, potentially raising the remedial efficacy against dual-infection scenarios. This highlights the fact that unremitting innovations in pharmaceutical formulations and the availability of combined therapy to address complex infectious diseases are concomitant efforts.
Product Description
Ofloxacin is a synthetic fluoroquinolone antibacterial compound containing fluorine, nitrogen, oxygen, carbon, and hydrogen within its molecular structure. It is characterized by broad spectrum antibacterial activity and works primarily by interfering with bacterial enzymes involved in DNA replication and repair. The compound is generally handled as a pharmaceutical active ingredient and is incorporated into various dosage forms according to therapeutic requirements. Ofloxacin is used in selected treatments for bacterial infections and has applications in oral and ophthalmic pharmaceutical formulations. Its chemical structure provides useful stability and biological activity, making it an established component of generic pharmaceutical manufacturing. Production involves multiple chemical synthesis stages using pharmaceutical intermediates and specialized processing conditions.
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Ofloxacin |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Ofloxacin Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of ofloxacin pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting ofloxacin price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The ofloxacin price charts ensure our clients remain at the forefront of the industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Request Customization
Inquire Before Buying
Speak to an Analyst
Request Brochure
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-201-971-6302
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: [email protected]
Client Testimonials
.webp)
.webp){kind=logo}
Related Reports
Why Choose Us
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
Robust Methodologies & Extensive Resources
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Subscription-Based Databases
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Primary Research-Driven Insights
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
Extensive Secondary Research
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.